News | February 23, 2022
Agilent posts Q1 FY2022 revenue at US$ 1.67 billion
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
The facility will manufacture its Herceptin biosimilar, Tuznue
9T Labs provides a cost-competitive solution for manufacturing that will allow structural CFRP parts to replace metals at a much faster rate in demanding applications in many sectors such as aerospace, automotive and healthcare
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
The grants are expected to be received over the next three years, commencing March 2022
The transaction generates upfront cash proceeds of $442 million for Syncona's holding in Gyroscope
These programs are: Herpes simplex virus (HSV) vaccine candidate, Varicella-zoster virus (VZV) vaccine candidate and Checkpoint cancer vaccine.
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
Lenalidomide Sandoz is indicated for use in several critical haematology-oncology conditions, per latest ESMO guidelines
Subscribe To Our Newsletter & Stay Updated
